Extrapolating AUC to Infinity
AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…
CertaraMay 15, 2025
Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?
Part 3 in November: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling &…
CertaraMay 12, 2025
QSP Summit 2025: A New Standard in the Future of Drug Development
May 5, 2025 The Quantitative Systems Pharmacology (QSP) Summit 2025, hosted by Certara, marked another…
CertaraMay 5, 2025
Certara Reports First Quarter 2025 Financial Results
RADNOR, PA— May 5, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…
CertaraMay 5, 2025
Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk
Learn how a stepwise C-QTc approach can streamline cardiac safety evaluation, reduce costs, and align…
CertaraMay 5, 2025
Annual European Futbol Pharmacometrics Collective
Date: Wednesday, June 4Time: 6:00 PM – 10:00 PMLocation: Football Sport Center — 47 Poseidonos…
CertaraMay 1, 2025
A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition
The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter…
CertaraApril 30, 2025
Clinical validation of a quantitative systems pharmacology (QSP) model of ISB 2001 used for deriving first in human (FIH) dose and efficient phase 1 dose escalation design in relapsed/refractory multiple myeloma (RRMM) patient
In partnership with Ichnos, Certara developed a QSP model to determine the most suitable therapeutic…
CertaraApril 30, 2025
